These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Metabolic activation of aromatic amine carcinogens in vitro and in vivo. Beland FA. J UOEH; 1989 Mar 20; 11 Suppl():387-97. PubMed ID: 2664951 [No Abstract] [Full Text] [Related]
12. The effects of discontinuing administration of high levels of 2-acetylaminofluorene on the transitional epithelium of the mouse urinary bladder. Frith CH, Rule JE. J Environ Pathol Toxicol; 1978 Mar 20; 1(5):581-5. PubMed ID: 722205 [Abstract] [Full Text] [Related]
13. Influence of total dose and dose rate in carcinogenicity studies. Littlefield NA, Gaylor DW. J Toxicol Environ Health; 1985 Mar 20; 15(5):545-50. PubMed ID: 4046064 [Abstract] [Full Text] [Related]
14. Urinary bladder neoplasms induced in BALB/c female mice with low doses of 2-acetylaminofluorene. Gaylor DW, Greenman DL, Frith CH. J Environ Pathol Toxicol Oncol; 1985 Mar 20; 6(1):127-36. PubMed ID: 4067830 [Abstract] [Full Text] [Related]
15. [Effect of 2 different carcinogens used separately and in combination on the liver carcinogenesis in rodents]. Wojnar A. Patol Pol; 1980 Mar 20; 31(3):405-15. PubMed ID: 6784094 [No Abstract] [Full Text] [Related]
17. Lack of p53 Ser389 phosphorylation predisposes mice to develop 2-acetylaminofluorene-induced bladder tumors but not ionizing radiation-induced lymphomas. Hoogervorst EM, Bruins W, Zwart E, van Oostrom CT, van den Aardweg GJ, Beems RB, van den Berg J, Jacks T, van Steeg H, de Vries A. Cancer Res; 2005 May 01; 65(9):3610-6. PubMed ID: 15867355 [Abstract] [Full Text] [Related]